2025 H2 -tulosraportti
UUTTA
Tänään
‧38 min
Tarjoustasot
Oslo Børs
Määrä
Osto
1 000
Myynti
Määrä
1 875
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 65 | - | - | ||
| 798 | - | - | ||
| 43 | - | - | ||
| 254 | - | - | ||
| 27 | - | - |
Ylin
4,76VWAP
Alin
4,44VaihtoMäärä
12,8 2 748 095
VWAP
Ylin
4,76Alin
4,44VaihtoMäärä
12,8 2 748 095
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·3 t sittenAnyone else looking forward to tomorrow? I am. Good night, see you tomorrow. What tomorrow might bring in connection with MSCI inclusion From ChatGPT 📊 What can happen tomorrow (trading on Oslo Børs) 🟢 Potential price increase – It is common for the price to move up on the day it becomes effective, especially if many index portfolios buy early in the day or towards the end of trading hours.  🔵 Increased volume – You will likely see more activity than normal, especially in the closing auction in the afternoon when index funds complete their purchases.  🔴 Volatility – The price can fluctuate more than usual throughout the day as traders also react to rebalancing orders and short-term investments. ⸻ ⏱️ Practical timing • The effect occurs from tomorrow's closing auction, meaning when the stock exchange closes trading, and the index change is implemented.  • The biggest effect on price and volume is often the end of the day and the day after. ⸻ 🧠 Briefly summarized ✅ MSCI inclusion means greater demand from funds that must buy the stock.  ✅ It has a positive short-term effect on the price through increased demand.  ✅ Tomorrow, higher volume and potential upside are expected, especially towards/after the closing auction.
·5 t sitten · MuokattuJust have to say it: today's report was simply… delightful. Not because we got fireworks, confetti and a stock price in a vertical position. But because we got something much better. We got confirmation. Thor isn't waving around powerpoint and buzzwords. They build. They deliver. They adjust capacity because the demand is actually there. It's almost boringly mature. And I like that. The stock price didn't run away. No FOMO party. No 30 % spike and 18 % dump the day after. (🤞) Just a calm, almost slightly arrogant: “Yes, this is going as planned.” I bought my first shares at 1 kr. Back then it was more hope than track record. A bit like: “What if…” Now we have a factory on schedule, guidance intact and a management that actually does what they say they will do. That alone is almost exotic on the stock market. And then I have to laugh a bit at the analysis that prices it as if everything will be delayed until 2030 and half the factory blows away in a headwind. At the same time, the company just stands there and… keeps building. It's almost enough to make you smile. This is not biotechbingo. This is industry with backbone. Not a rocket. Not a castle in the air. More like… a slow-moving snowplow that just clears the way while people stand around discussing the weather forecast. I'm sitting here with a calm pulse and polishing the goat horns. From 1 kr until today, and it feels more solid now than ever. Fantastic? Yes. Hysterical? No. Confident? Absoluttt.
·8 t sitten · MuokattuPoor response to today's report🤷♂️?It's being sold off heavily. Thought it would skyrocket today.
·9 t sittenWhat is the name of the genius at DNB Carnegie who has analyzed Thor Medical and who is his client😎😎😎????Oslo Børs at its best🤔🤔
9 t sitten9 t sittenAlphaOne on Track, Backed by Strong Commercial Momentum📊🏗️ Thor Medical today announced interim results for the second half and full year 2025. “Last year we demonstrated that our technology works through the successful production and delivery of high-purity isotopes to customers. Entering 2026, Thor Medical has a strong funding position to execute on our development and ramp-up plans. We expect revenue to increase from the second half of 2026, supporting our ambition to generate positive cash flow by the end of 2027”, said Jasper C. Kurth, CEO of Thor Medical. Key development highlights for the period include: · Executed final investment decision and began construction of AlphaOne at Herøya Industripark AS · Signed strategic sourcing agreement for thorium-232 feedstock with European chemical group · Shipped first batch of ultra-high purity Pb-212 to big pharma customer · Increased order backlog to NOK ~850 million through multi-year sales agreements with new and existing customers · Completed initial equipment installations and official takeover of the new Herøya laboratory and infrastructure · Secured funding for AlphaOne through NOK 300 million of total equity raised and NOK 90 million loan commitment from Innovasjon Norge · Strengthened executive team with hirings of Therese M. Kvehaugen and Mathias Nilsen Reierth Thor Medical has started the mechanical completion phase for AlphaOne and will prepare for testing, calibration and commissioning of installed industrial-scale equipment over the coming months, with mechanical completion expected in April. The Company’s financial position remains strong with cash and cash equivalents at the end of the period of NOK 180.6 million, securing AplhaOne execution and ramp-up until positive cash flow.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H2 -tulosraportti
UUTTA
Tänään
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenAnyone else looking forward to tomorrow? I am. Good night, see you tomorrow. What tomorrow might bring in connection with MSCI inclusion From ChatGPT 📊 What can happen tomorrow (trading on Oslo Børs) 🟢 Potential price increase – It is common for the price to move up on the day it becomes effective, especially if many index portfolios buy early in the day or towards the end of trading hours.  🔵 Increased volume – You will likely see more activity than normal, especially in the closing auction in the afternoon when index funds complete their purchases.  🔴 Volatility – The price can fluctuate more than usual throughout the day as traders also react to rebalancing orders and short-term investments. ⸻ ⏱️ Practical timing • The effect occurs from tomorrow's closing auction, meaning when the stock exchange closes trading, and the index change is implemented.  • The biggest effect on price and volume is often the end of the day and the day after. ⸻ 🧠 Briefly summarized ✅ MSCI inclusion means greater demand from funds that must buy the stock.  ✅ It has a positive short-term effect on the price through increased demand.  ✅ Tomorrow, higher volume and potential upside are expected, especially towards/after the closing auction.
- ·5 t sitten · MuokattuJust have to say it: today's report was simply… delightful. Not because we got fireworks, confetti and a stock price in a vertical position. But because we got something much better. We got confirmation. Thor isn't waving around powerpoint and buzzwords. They build. They deliver. They adjust capacity because the demand is actually there. It's almost boringly mature. And I like that. The stock price didn't run away. No FOMO party. No 30 % spike and 18 % dump the day after. (🤞) Just a calm, almost slightly arrogant: “Yes, this is going as planned.” I bought my first shares at 1 kr. Back then it was more hope than track record. A bit like: “What if…” Now we have a factory on schedule, guidance intact and a management that actually does what they say they will do. That alone is almost exotic on the stock market. And then I have to laugh a bit at the analysis that prices it as if everything will be delayed until 2030 and half the factory blows away in a headwind. At the same time, the company just stands there and… keeps building. It's almost enough to make you smile. This is not biotechbingo. This is industry with backbone. Not a rocket. Not a castle in the air. More like… a slow-moving snowplow that just clears the way while people stand around discussing the weather forecast. I'm sitting here with a calm pulse and polishing the goat horns. From 1 kr until today, and it feels more solid now than ever. Fantastic? Yes. Hysterical? No. Confident? Absoluttt.
- ·8 t sitten · MuokattuPoor response to today's report🤷♂️?It's being sold off heavily. Thought it would skyrocket today.
- ·9 t sittenWhat is the name of the genius at DNB Carnegie who has analyzed Thor Medical and who is his client😎😎😎????Oslo Børs at its best🤔🤔
- 9 t sitten9 t sittenAlphaOne on Track, Backed by Strong Commercial Momentum📊🏗️ Thor Medical today announced interim results for the second half and full year 2025. “Last year we demonstrated that our technology works through the successful production and delivery of high-purity isotopes to customers. Entering 2026, Thor Medical has a strong funding position to execute on our development and ramp-up plans. We expect revenue to increase from the second half of 2026, supporting our ambition to generate positive cash flow by the end of 2027”, said Jasper C. Kurth, CEO of Thor Medical. Key development highlights for the period include: · Executed final investment decision and began construction of AlphaOne at Herøya Industripark AS · Signed strategic sourcing agreement for thorium-232 feedstock with European chemical group · Shipped first batch of ultra-high purity Pb-212 to big pharma customer · Increased order backlog to NOK ~850 million through multi-year sales agreements with new and existing customers · Completed initial equipment installations and official takeover of the new Herøya laboratory and infrastructure · Secured funding for AlphaOne through NOK 300 million of total equity raised and NOK 90 million loan commitment from Innovasjon Norge · Strengthened executive team with hirings of Therese M. Kvehaugen and Mathias Nilsen Reierth Thor Medical has started the mechanical completion phase for AlphaOne and will prepare for testing, calibration and commissioning of installed industrial-scale equipment over the coming months, with mechanical completion expected in April. The Company’s financial position remains strong with cash and cash equivalents at the end of the period of NOK 180.6 million, securing AplhaOne execution and ramp-up until positive cash flow.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
1 000
Myynti
Määrä
1 875
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 65 | - | - | ||
| 798 | - | - | ||
| 43 | - | - | ||
| 254 | - | - | ||
| 27 | - | - |
Ylin
4,76VWAP
Alin
4,44VaihtoMäärä
12,8 2 748 095
VWAP
Ylin
4,76Alin
4,44VaihtoMäärä
12,8 2 748 095
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
2025 H2 -tulosraportti
UUTTA
Tänään
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenAnyone else looking forward to tomorrow? I am. Good night, see you tomorrow. What tomorrow might bring in connection with MSCI inclusion From ChatGPT 📊 What can happen tomorrow (trading on Oslo Børs) 🟢 Potential price increase – It is common for the price to move up on the day it becomes effective, especially if many index portfolios buy early in the day or towards the end of trading hours.  🔵 Increased volume – You will likely see more activity than normal, especially in the closing auction in the afternoon when index funds complete their purchases.  🔴 Volatility – The price can fluctuate more than usual throughout the day as traders also react to rebalancing orders and short-term investments. ⸻ ⏱️ Practical timing • The effect occurs from tomorrow's closing auction, meaning when the stock exchange closes trading, and the index change is implemented.  • The biggest effect on price and volume is often the end of the day and the day after. ⸻ 🧠 Briefly summarized ✅ MSCI inclusion means greater demand from funds that must buy the stock.  ✅ It has a positive short-term effect on the price through increased demand.  ✅ Tomorrow, higher volume and potential upside are expected, especially towards/after the closing auction.
- ·5 t sitten · MuokattuJust have to say it: today's report was simply… delightful. Not because we got fireworks, confetti and a stock price in a vertical position. But because we got something much better. We got confirmation. Thor isn't waving around powerpoint and buzzwords. They build. They deliver. They adjust capacity because the demand is actually there. It's almost boringly mature. And I like that. The stock price didn't run away. No FOMO party. No 30 % spike and 18 % dump the day after. (🤞) Just a calm, almost slightly arrogant: “Yes, this is going as planned.” I bought my first shares at 1 kr. Back then it was more hope than track record. A bit like: “What if…” Now we have a factory on schedule, guidance intact and a management that actually does what they say they will do. That alone is almost exotic on the stock market. And then I have to laugh a bit at the analysis that prices it as if everything will be delayed until 2030 and half the factory blows away in a headwind. At the same time, the company just stands there and… keeps building. It's almost enough to make you smile. This is not biotechbingo. This is industry with backbone. Not a rocket. Not a castle in the air. More like… a slow-moving snowplow that just clears the way while people stand around discussing the weather forecast. I'm sitting here with a calm pulse and polishing the goat horns. From 1 kr until today, and it feels more solid now than ever. Fantastic? Yes. Hysterical? No. Confident? Absoluttt.
- ·8 t sitten · MuokattuPoor response to today's report🤷♂️?It's being sold off heavily. Thought it would skyrocket today.
- ·9 t sittenWhat is the name of the genius at DNB Carnegie who has analyzed Thor Medical and who is his client😎😎😎????Oslo Børs at its best🤔🤔
- 9 t sitten9 t sittenAlphaOne on Track, Backed by Strong Commercial Momentum📊🏗️ Thor Medical today announced interim results for the second half and full year 2025. “Last year we demonstrated that our technology works through the successful production and delivery of high-purity isotopes to customers. Entering 2026, Thor Medical has a strong funding position to execute on our development and ramp-up plans. We expect revenue to increase from the second half of 2026, supporting our ambition to generate positive cash flow by the end of 2027”, said Jasper C. Kurth, CEO of Thor Medical. Key development highlights for the period include: · Executed final investment decision and began construction of AlphaOne at Herøya Industripark AS · Signed strategic sourcing agreement for thorium-232 feedstock with European chemical group · Shipped first batch of ultra-high purity Pb-212 to big pharma customer · Increased order backlog to NOK ~850 million through multi-year sales agreements with new and existing customers · Completed initial equipment installations and official takeover of the new Herøya laboratory and infrastructure · Secured funding for AlphaOne through NOK 300 million of total equity raised and NOK 90 million loan commitment from Innovasjon Norge · Strengthened executive team with hirings of Therese M. Kvehaugen and Mathias Nilsen Reierth Thor Medical has started the mechanical completion phase for AlphaOne and will prepare for testing, calibration and commissioning of installed industrial-scale equipment over the coming months, with mechanical completion expected in April. The Company’s financial position remains strong with cash and cash equivalents at the end of the period of NOK 180.6 million, securing AplhaOne execution and ramp-up until positive cash flow.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
1 000
Myynti
Määrä
1 875
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 65 | - | - | ||
| 798 | - | - | ||
| 43 | - | - | ||
| 254 | - | - | ||
| 27 | - | - |
Ylin
4,76VWAP
Alin
4,44VaihtoMäärä
12,8 2 748 095
VWAP
Ylin
4,76Alin
4,44VaihtoMäärä
12,8 2 748 095
Välittäjätilasto
Dataa ei löytynyt